JSE-listed pharmaceutical manufacturer Aspen has once again resumed dividends and will pay out R1.2-billion, or 262c apiece, to shareholders for the financial year ended June 30. The group’s normalised earnings before interest, taxes, depreciation and amortisation (Ebitda) for the 30 came in 3% higher year-on-year at R9.9-billion, as a lower gross profit percentage and reduced “other” operating income were partially offset by controlled operating expenses.
from Engineering News | Home https://ift.tt/3gXwFES